Cyclacel Pharmaceuticals, Inc.
CYCC
$0.299
-$0.0068-2.22%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
3/24/2025
-
GuruFocus
3/24/2025
-
Seeking Alpha - Healthcare
3/24/2025
-
TipRanks Financial Blog
3/24/2025
-
Globe Newswire
3/17/2025
-
Ticker Report
3/16/2025
-
Ticker Report
3/1/2025
-
MarketBeat
2/27/2025
-
GuruFocus
2/27/2025
-
Globe Newswire
2/15/2025
-
GuruFocus
1/27/2025
-
Ticker Report
1/20/2025
-
Ticker Report
1/12/2025
-
Ticker Report
1/6/2025
-
TipRanks Financial Blog
1/3/2025
-
Benzinga
1/3/2025
-
GuruFocus
1/3/2025
-
Seeking Alpha - Healthcare
1/3/2025
-
Globe Newswire
1/3/2025
-
FierceBiotech.com - Biotech
1/3/2025
-
Ticker Report
12/26/2024
-
Ticker Report
12/18/2024
-
Ticker Report
12/10/2024
-
Ticker Report
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, November 12, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Mar 17 and 21 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
908 517 7330
Address
200 Connell Drive
Berkeley Heights, NJ 07922
Berkeley Heights, NJ 07922
Country
Year Founded
Business Description
Sector
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases in the United States, the United...
more
